HK1

Chr 10

hexokinase 1

Also known as: CNSHA5, HK, HK1-ta, HK1-tb, HK1-tc, HKD, HKI, HMSNR

Hexokinases phosphorylate glucose to produce glucose-6-phosphate, the first step in most glucose metabolism pathways. This gene encodes a ubiquitous form of hexokinase which localizes to the outer membrane of mitochondria. Mutations in this gene have been associated with hemolytic anemia due to hexokinase deficiency. Alternative splicing of this gene results in several transcript variants which encode different isoforms, some of which are tissue-specific. [provided by RefSeq, Apr 2016]

GeneReviewsResearchGenerating clinical summary…
MultiplemechanismLOEUF 0.33
Clinical SummaryHK1
Population Constraint (gnomAD)
Highly constrained gene — heterozygous loss-of-function variants are very rare in the population (pLI 0.91). One damaged copy is likely sufficient to cause disease.
📋
ClinVar Variants
40 unique Pathogenic / Likely Pathogenic· 426 VUS of 855 total submissions
📖
GeneReview available — HK1
Authoritative clinical overview · Recommended first read
Open GeneReview ↗
Some data sources returned errors (1)

omim: Error: OMIM fetch failed: 429

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Dual constrained — LoF & missense intolerant
LoF Constraint?
0.33LOEUF
pLI 0.915
Z-score 4.96
OE 0.19 (0.110.33)
Highly constrained

Highly LoF-intolerant (top ~10% of genes)

Missense Constraint?
3.23Z-score
OE missense 0.61 (0.560.67)
341 obs / 555.3 exp
Constrained

Highly missense-constrained (top ~0.1%)

Observed / Expected Ratios?
LoF OE?0.19 (0.110.33)
00.351.4
Missense OE?0.61 (0.560.67)
00.61.4
Synonymous OE?0.94
01.21.6
LoF obs/exp: 8 / 43.2Missense obs/exp: 341 / 555.3Syn Z: 0.73
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
strongHK1-related neurodevelopmental disorder with visual defects and brain anomaliesOTHERAD
limitedHK1-related retinitis pigmentosaOTHERAD

This gene — mechanism propensity

DN
0.5280th %ile
GOF
0.5660th %ile
LOF
0.4430th %ile

This gene has evidence for multiple mechanisms of pathogenicity (loss-of-function and gain-of-function). The Badonyi & Marsh model scores gain-of-function highest among its predictions, but genomic evidence (constraint, ClinVar variant spectrum, and literature) most strongly supports loss-of-function (haploinsufficiency). Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

LOF43% of P/LP variants are LoF · LOEUF 0.33
GOF1 literature citation

Literature Evidence

GOFBiochemical assays showed that the E847K mutation does not affect hexokinase enzymatic activity or the protein stability, suggesting that the mutation may impact other uncharacterized function or result in a gain of function of HK1.1

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312. Mechanism ranking also informed by gnomAD constraint, ClinVar, and ClinGen data.

References

  1. 1.PMID 25316723

ClinVar Variant Classifications

855 submitted variants in ClinVar

Classification Summary

Pathogenic11
Likely Pathogenic29
VUS426
Likely Benign321
Benign31
Conflicting19
11
Pathogenic
29
Likely Pathogenic
426
VUS
321
Likely Benign
31
Benign
19
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
9
2
0
0
11
Likely Pathogenic
8
17
4
0
29
VUS
12
385
24
5
426
Likely Benign
0
4
125
192
321
Benign
0
6
18
7
31
Conflicting
19
Total29414171204837

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

14 pathogenic / likely-pathogenic (of 17) ClinVar copy-number / structural variants overlap HK1 — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

HK1 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →